Detail page

Knowledge Web

Person

Gabriela Riemekasten (1965-)

Internistin

Name	Gabriela Riemekasten
Time	1965- (Date of birth and death)
Place	Lübeck (Wirkungsort) Deutschland
Gender	weiblich
Academic degree	Prof. Dr. med.
Profession	Internistin (characteristic profession)
Related	Universitätsklinikum Schleswig-Holstein (Direktorin der Klinik für Rheumatologie)
Source	Vorlage
Record type	Person
GND-Identifier	125842406
Record ID	125842406
Involved in show all Interdisziplinäre Zentren für Autoimmunerkrankungen in Deutschland Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation Recommendations for defining giant cell arteritis fast-track clinics = Empfehlungen zur Definition von Riesenzellarteriitis-Fast-Track-Kliniken Epidemiologische Daten und medizinische Versorgungssituation von Patienten mit chronischen Entzündungserkrankungen in Deutschland : Real-World-Evidenz zu Prävalenz, Erkrankungskombinationen, Versorgung Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc Nuclear antigen–reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys Identification and characterization of antigen-specific CD4+ T cells targeting renally expressed antigens in human lupus nephritis with two independent methods Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets Versorgungsrealität der stationären vasoaktiven Therapie mit Prostazyklinderivaten bei Patienten mit akralen Durchblutungsstörungen bei systemischer Sklerose in Deutschland = Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis Contributions to the 2nd Symposium on Regulatory Autoantibodies Targeting G-Protein-Coupled Receptors GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4 + and CD8 + T cells and macrophages Mechanisms of Autoantibody-Induced Pathology PAH im Rahmen von entzündlich-rheumatischen Erkrankungen 1st Symposium on Functional Autoantibodies Targeting G-Protein-Coupled Receptors : book of abstracts Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy Die Rolle eines SmD1-Peptids bei der Entstehung von pathogenetisch bedeutsamen Autoantikörpern beim systemischen Lupus erythematodes Die Rolle eines SmD1-Peptids bei der Entstehung von pathogenetisch bedeutsamen Autoantikörpern beim systemischen Lupus erythematodes Untersuchungen zum Nachweis von Autoantikörpern gegen extrahierbare nucleäre Antigene mittels Immunoblotting und ihre diagnostische Bedeutung beim SLE

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Gabriela Riemekasten (1965-)

Interdisziplinäre Zentren für Autoimmunerkrankungen in Deutschland

Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation

Recommendations for defining giant cell arteritis fast-track clinics = Empfehlungen zur Definition von Riesenzellarteriitis-Fast-Track-Kliniken

Epidemiologische Daten und medizinische Versorgungssituation von Patienten mit chronischen Entzündungserkrankungen in Deutschland : Real-World-Evidenz zu Prävalenz, Erkrankungskombinationen, Versorgung

Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach

Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc

Nuclear antigen–reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys

Identification and characterization of antigen-specific CD4+ T cells targeting renally expressed antigens in human lupus nephritis with two independent methods

Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis

Contributions to the 2nd Symposium on Regulatory Autoantibodies Targeting G-Protein-Coupled Receptors

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides

Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4 + and CD8 + T cells and macrophages

Mechanisms of Autoantibody-Induced Pathology

PAH im Rahmen von entzündlich-rheumatischen Erkrankungen

1st Symposium on Functional Autoantibodies Targeting G-Protein-Coupled Receptors : book of abstracts

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis

Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group

Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features

High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

Die Rolle eines SmD1-Peptids bei der Entstehung von pathogenetisch bedeutsamen Autoantikörpern beim systemischen Lupus erythematodes

Die Rolle eines SmD1-Peptids bei der Entstehung von pathogenetisch bedeutsamen Autoantikörpern beim systemischen Lupus erythematodes

Untersuchungen zum Nachweis von Autoantikörpern gegen extrahierbare nucleäre Antigene mittels Immunoblotting und ihre diagnostische Bedeutung beim SLE